Skip to main content
. 2016 Dec 12;11(12):e0168135. doi: 10.1371/journal.pone.0168135

Fig 6. NK/NKT and dendritic cells in GD patients.

Fig 6

NK cells (CD3-/ CD16+ or CD56+), NKT cells (CD3+/ CD16+ or CD56+) and invariant NKT cells (iNKT, CD3+, Vα24Jα18+, CD4+/CD8+) from peripheral blood of GD patients and normal controls were assessed using flow cytometry and plotted as percentage of total lymphocytes (A-D). Dendritic cells were enumerated as Lin-/CD34-/HLA DR+ cells and plotted as a percentage of total leukocytes/WBCs (E). Dendritic cells were further fractionated as myeloid DCs or plasmacytoid DCs based on expression of CD11c and BDCA2 respectively and plotted as percentage of DCs (F&G).